Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178670-25-000090
Filing Date
2025-07-31
Accepted
2025-07-31 08:11:22
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alny-20250630.htm   iXBRL 10-Q 1893540
2 EX-31.1 alny2025q210-qex311.htm EX-31.1 9177
3 EX-31.2 alny2025q210-qex312.htm EX-31.2 9178
4 EX-32.1 alny2025q210-qex321.htm EX-32.1 4106
5 EX-32.2 alny2025q210-qex322.htm EX-32.2 4120
11 alny-20250630_g1.jpg GRAPHIC 402805
  Complete submission text file 0001178670-25-000090.txt   8824525

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alny-20250630.xsd EX-101.SCH 52339
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alny-20250630_cal.xml EX-101.CAL 64487
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alny-20250630_def.xml EX-101.DEF 237276
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alny-20250630_lab.xml EX-101.LAB 562064
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alny-20250630_pre.xml EX-101.PRE 420342
81 EXTRACTED XBRL INSTANCE DOCUMENT alny-20250630_htm.xml XML 1265565
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 251169534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)